Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor

被引：28
|
作者：
Singh, Sameek [1 ]
Oyagawa, Caitlin R. M. [2 ,3 ]
Macdonald, Christa [2 ,3 ]
Grimsey, Natasha L. [2 ,3 ]
Glass, Michelle [2 ,3 ,4 ]
Vernall, Andrea J. [1 ]
机构：
[1] Univ Otago, Sch Pharm, Dunedin, New Zealand
[2] Univ Auckland, Sch Med Sci, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland, New Zealand
[3] Univ Auckland, Sch Med Sci, Ctr Brain Res, Fac Med & Hlth Sci, Auckland, New Zealand
[4] Univ Otago, Dept Pharmacol & Toxicol, Dunedin 9016, New Zealand
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 02期
关键词：
GPCR; cannabinoid type 2 receptor; fluorescent ligand; chemical tool; CB2; RECEPTOR; ENDOCANNABINOID SYSTEM; SCAFFOLD; AGONISTS; PROBES; TOOLS;
D O I：
10.1021/acsmedchemlett.8b00597
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cannabinoid type 2 receptor (CB2R) is an attractive target for the treatment of pain and inflammatory disorders. Availability of a selective CB2R fluorescent ligand to study CB2R expression and localization in healthy and disease conditions would greatly contribute to improving our understanding of this receptor. Herein, we report a series of chromenopyrazole-based CB2R fluorescent ligands. The highest affinity fluorescent ligand was Cy5-containing 24 (hCB(2)R pK(i), = 7.38 +/- 0.05), which had 131-fold selectivity over CB1R. In a cAMP BRET assay, 24 behaved as a potent CB2R. inverse agonist. Widefield imaging experiments showed that 24 binds to CB2R in live cells with good selectivity and low levels of nonspecific fluorescence. The high affinity, selectivity, and suitable imaging properties of fluorescent ligand 24 make it a valuable tool for studying CB2R.
引用
收藏
页码：209 / 214
页数：11
相关论文
共 50 条
  • [41] NEW INSIGHT INTO STRUCTURAL AND STEREOCHEMICAL REQUIREMENTS FOR SELECTIVE, HIGH-AFFINITY LIGANDS AT THE DOPAMINE D2 RECEPTOR
    IMHOF, R
    GODEL, T
    BURKARD, WP
    KELLER, HH
    DAPRADA, M
    SCHERSCHLICHT, R
    NEUROCHEMISTRY INTERNATIONAL, 1992, 20 : S75 - S80
  • [42] Mechanistic QSAR analysis to predict the binding affinity of diverse heterocycles as selective cannabinoid 2 receptor inhibitor
    Jawarkar, Rahul D.
    Zaki, Magdi E. A.
    Al-Hussain, Sami A.
    Alzahrani, Abdullah Yahya Abdullah
    Ming, Long Chiau
    Samad, Abdul
    Rashid, Summya
    Mali, Suraj
    Elossaily, Gehan M.
    JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE, 2023, 17 (01):
  • [43] Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands
    Poso, A.
    Huffman, J. W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 335 - 346
  • [44] Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type2 Ligands
    Ragusa, Giulio
    Bencivenni, Serena
    Morales, Paula
    Callaway, Tyra
    Hurst, Dow P.
    Asproni, Battistina
    Merighi, Stefania
    Loriga, Giovanni
    Pinna, Gerard A.
    Reggio, Patricia H.
    Gessi, Stefania
    Murineddu, Gabriele
    CHEMMEDCHEM, 2018, 13 (11) : 1102 - 1114
  • [45] Targeting the cannabinoid CB2 receptor:: Mutations, modeling and development of CB2 selective ligands
    Raitio, KH
    Salo, OMH
    Nevalainen, T
    Poso, A
    Järvinen, T
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (10) : 1217 - 1237
  • [46] Exploration of natural and synthetic N-alkyl amides as source for new cannabinoid receptor type-2 (CB2) selective ligands
    Gertsch, J.
    Raduner, S.
    Chicca, A.
    Feyen, F.
    Altmann, K. H.
    PLANTA MEDICA, 2007, 73 (09) : 843 - 843
  • [47] Design of high-affinity gip receptor ligands
    Hansen, Lrke Smidt
    Sparre-Ulrich, Alexander Hovard
    Christensen, Mikkel
    Knop, Filip Krag
    Holst, Jens Juul
    Rosenkilde, Mette Marie
    MEDICINE, 2016, 95 (10)
  • [48] The First Photochromic Affinity Switch for the Human Cannabinoid Receptor 2
    Dolles, Dominik
    Strasser, Andrea
    Wittmann, Hans-Joachim
    Marinelli, Oliviero
    Nabissi, Massimo
    Pertwee, Roger G.
    Decker, Michael
    ADVANCED THERAPEUTICS, 2018, 1 (01)
  • [49] Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands:: Consequences in receptor affinity and functionality
    Stern, Eric
    Muccioli, Giulio G.
    Bosier, Barbara
    Hamtiaux, Laurie
    Millet, Regis
    Poupaert, Jacques H.
    Henichart, Jean-Pierre
    Depreux, Patrick
    Goossens, Jean-Francois
    Lambert, Didier M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) : 5471 - 5484
  • [50] A NOVEL ELECTROPHILIC HIGH-AFFINITY IRREVERSIBLE PROBE FOR THE CANNABINOID RECEPTOR
    MORSE, KL
    FOURNIER, DJ
    LI, XY
    GRZYBOWSKA, J
    MAKRIYANNIS, A
    LIFE SCIENCES, 1995, 56 (23-24) : 1957 - 1962
12345